Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 11.43 +0.61 (5.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.82 | 52 Week High | $9.23 | |||
| Open | $10.75 | 52 Week Low | $1.16 | |||
| Day High | $11.57 | P/E | N/A | |||
| Day Low | $10.55 | EPS | $-0.30 | |||
| Volume | 6,520,616 | |||||
